How Can Variable Patient Groups Be Addressed in CAR T?

https://vimeo.com/944065239 Can CAR T-cell therapy address variable patient groups? Expert Dr. Krina Patel from The University of Texas MD Anderson Cancer Center discusses variances in different myeloma patient groups, the KarMMa-3 study,…

Understanding Myeloma Therapy Targets BCMA and GPRC5D

https://vimeo.com/936716579 What are myeloma targets, and how do they impact the effectiveness of therapy? Dr. Krina Patel explains how treatments like bispecific antibodies and CAR T-cell therapy are using myeloma…

How Is CAR T-Cell Therapy Research Advancing Myeloma Care?

https://vimeo.com/936716514 What progress is being made in furthering advancing CAR T-cell therapy for myeloma? Dr. Krina Patel discusses the manufacturing process for CAR T-cells, research updates for manufacturing CAR T-cells…

Myeloma Symptom Management | An Expert’s Approach

https://vimeo.com/936832068 How are myeloma symptoms and treatment side effects managed? Dr. Sikander Ailawadhi discusses the importance of addressing symptoms, management approaches, and the necessity of communication between the patient and…

Share On:

Facebook
Twitter
LinkedIn